Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShearwater Regulatory News (SWG)

Share Price Information for Shearwater (SWG)

Share Price is delayed by 15 minutes
Get Live Data
37.00    0.00 (0.00%)
Bid:
36.00
Ask:
38.00
Spread: 2.00 (5.556%)
Market Cap: £8.82m
SWG Live PriceLast checked at - London Stock Exchange

Intraday Shearwater Share Chart

Rule 8.3- Aurum Mining Plc

17 Dec 2008 13:36

RNS Number : 3136K
Midas Capital Partners Limited
17 December 2008
 



FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

Midas Capital plc

Company dealt in

Aurum Mining plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary 1p Shares

Date of dealing

16/09/08

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities 

2,450,000

5.08

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

2,450,000

5.08

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

Details

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale 

Number of securities

Price per unit (Note 5)

Purchase

250,000

0.255(GBP)

 

(b) Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product

name, e.g.

call option 

Writing,

selling,

purchasing,

varying etc.

Number of

securities to

which the

option

relates

(Note 7)

Exercise

price 

Type, e.g.

American,

European

etc.

Expiry

date

Option

money

paid/received

per unit (Note

5) 

 

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)

NO

 

Date of disclosure

17/12/08

Contact name

Elaine Smith

Telephone number

0151 906 2468

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETXDLFFVLBXFBL
Date   Source Headline
9th Aug 20215:43 pmRNSDirector/PDMR Shareholding
28th Jul 20217:00 amRNSFinal Results
20th Jul 20217:00 amRNSNotice of Results and Presentation to Investors
13th Jul 202111:39 amRNSHolding(s) in Company
6th May 20217:00 amRNSFramework Agreement Renewal
30th Apr 20213:21 pmRNSHolding(s) in Company
22nd Apr 20217:00 amRNSPost Close Trading Update
12th Mar 202110:42 amRNSHolding(s) in Company
26th Feb 20217:00 amRNSExercise of options
22nd Feb 20213:11 pmRNSHolding(s) in Company
15th Feb 202110:02 amRNSHolding(s) in Company
26th Jan 20217:00 amRNSGrant of Options under SAYE Scheme
11th Jan 20212:54 pmRNSHolding(s) in Company
6th Jan 20217:00 amRNSContract Win
29th Dec 20207:00 amRNSTrading update and New contracts secured
16th Dec 20207:00 amRNSHolding(s) in Company
8th Dec 20209:47 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSResults for the six months ended 30 September 2020
12th Nov 20207:00 amRNSNotice of Results and Presentation to Investors
22nd Oct 20207:00 amRNSH1 Trading update
25th Sep 20207:00 amRNSResult of AGM
14th Sep 20201:29 pmRNSRelease of Holdback Consideration Shares
1st Sep 20207:00 amRNSPosting of Annual Report and Notice of AGM
20th Aug 20207:00 amRNSTrading Update
29th Jul 20207:00 amRNSFinal Results
30th Jun 20207:00 amRNSNotice of Results
24th Apr 20204:41 pmRNSSecond Price Monitoring Extn
24th Apr 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20201:58 pmRNSResults of Placing and Total Voting Rights
24th Apr 20207:00 amRNSProposed placing
2nd Apr 20207:00 amRNSPre-close statement
27th Mar 20207:00 amRNSContract win
25th Mar 20207:00 amRNSStatement re COVID-19 and contract wins
24th Mar 20205:44 pmRNSHolding(s) in Company
26th Feb 20207:00 amRNSIssue of Equity
27th Nov 20197:00 amRNSInterim Results
19th Nov 201911:30 amRNSNotice of Results
30th Oct 20197:00 amRNSBrookcourt Solutions secures EUR 0.5 M contract
28th Oct 20198:53 amRNSDirector/PDMR Shareholding
24th Oct 20197:01 amRNSHalf year trading update
22nd Oct 20197:00 amRNSGroup wins 5 awards at Computing Security Awards
10th Oct 20197:00 amRNSBrookcourt Solutions secures £8.5m contract
26th Sep 20199:11 amRNSDirector/PDMR Shareholding
25th Sep 20191:41 pmRNSResult of AGM
17th Sep 20197:00 amRNSPentest secures million-dollar contract
2nd Sep 20197:05 amRNSIssue of Equity
2nd Sep 20197:00 amRNSNotice of AGM and Proposed Share Reorganisation
30th Aug 20198:30 amRNSSecurEnvoy signs distribution agreement
31st Jul 20197:00 amRNSFinal Results
26th Jul 20197:00 amRNSXcina Consulting secures contract with Parkmobile

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.